Citation: | WANG Yong-chao, ZHENG Zeng-guang. Effect and mechanism of berberine-targeted regulation of TLR4 signaling pathway on the biological behaviour of malignant melanoma[J]. Chinese Journal of General Practice, 2022, 20(1): 22-26, 53. doi: 10.16766/j.cnki.issn.1674-4152.002267 |
[1] |
TODO Y, OKAMOTO K, SUZUKI Y, et al. Radicality of initial surgery for primary malignant melanoma of the vagina[J]. Melanoma Res, 2016, 26(2): 173-180. doi: 10.1097/CMR.0000000000000239
|
[2] |
OHADIAN MOGHADAM S, NOWROOZI M R. Toll-like receptors: The role in bladder cancer development, progression and immunotherapy[J]. Scand J Immunol, 2019, 90(6): e12818.
|
[3] |
KHADEMALHOSSEINI M, ARABABADI M K. Toll-like receptor 4 and breast cancer: An updated systematic review[J]. Breast Cancer, 2019, 26(3): 265-271. doi: 10.1007/s12282-018-00935-2
|
[4] |
KHEDR L H, NASSAR N N, RASHED L, et al. TLR4 signaling modulation of PGC1-α mediated mitochondrial biogenesis in the LPS-Chronic mild stress model: Effect of fluoxetine and pentoxiyfylline[J]. Life Sci, 2019, 239: 116869. doi: 10.1016/j.lfs.2019.116869
|
[5] |
LI M, ZHANG M, ZHANG Z L, et al. Induction of apoptosis by berberine in hepatocellular carcinoma HepG2 cells via downregulation of NF-κB[J]. Oncol Res, 2017, 25(2): 233-239. doi: 10.3727/096504016X14742891049073
|
[6] |
TAN W, ZHONG Z, WANG S, et al. Berberine regulated lipid metabolism in the presence of C75, compound C, and TOFA in breast cancer cell line MCF-7[J]. Evid Based Complement Alternat Med, 2015, 2015: 396035.
|
[7] |
ZHU W, ZOU B, WANG S. Clinicopathological features and prognosis of sinonasal mucosal malignant melanoma: A retrospective study of 83 cases in a Chinese population[J]. ORL J Otorhinolaryngol Relat Spec, 2016, 78(2): 94-104. doi: 10.1159/000444500
|
[8] |
LEE A J, RO M, CHO K J, et al. Lipopolysaccharide/TLR4 stimulates IL-13 production through a MyD88-BLT2-Linked cascade in mast cells, potentially contributing to the allergic response[J]. J Immunol, 2017, 199(2): 409-417. doi: 10.4049/jimmunol.1602062
|
[9] |
ZHOU S, DU R, WANG Z, et al. TLR4 increases the stemness and is highly expressed in relapsed human hepatocellular carcinoma[J]. Cancer Med, 2019, 8(5): 2325-2337. doi: 10.1002/cam4.2070
|
[10] |
MIKAMI E, KUDO M, OHASHI R, et al. Toll-like receptor 4 plays a tumor-suppressive role in cutaneous squamous cell carcinoma[J]. Int J Oncol, 2019, 54(6): 2179-2188.
|
[11] |
MOSER V A, UCHOA M F, PIKE C J. TLR4 inhibitor TAK-242 attenuates the adverse neural effects of diet-induced obesity[J]. J Neuroinflammation, 2018, 15(1): 306. doi: 10.1186/s12974-018-1340-0
|
[12] |
SU C, LIU C, ZHAO L, et al. Amide proton transfer imaging allows detection of glioma grades and tumor proliferation: Comparison with Ki-67 expression and proton MR spectroscopy imaging[J]. AJNR Am J Neuroradiol, 2017, 38(9): 1702-1709. doi: 10.3174/ajnr.A5301
|
[13] |
DILLON C P, GREEN D R. Molecular cell biology of apoptosis and necroptosis in cancer[J]. Adv Exp Med Biol, 2016, 930: 1-23.
|
[14] |
LV Z, LIU M, SHEN J, et al. Association of serum interleukin-10, interleukin-17A and transforming growth factor-α levels with human benign and malignant breast diseases[J]. Exp Ther Med, 2018, 15(6): 5475-5480.
|
[15] |
GOLAN T, PARIKH R, JACOB E, et al. Adipocytes sensitize melanoma cells to environmental TGF-β cues by repressing the expression of miR-211[J]. Sci Signal, 2019, 12(591): eaav6847. DOI: 10.1126/scisignal.aav6847.
|